Josephine Torrente - Oct 7, 2021 Form 4 Insider Report for AGILE THERAPEUTICS INC (AGRX)

Role
Director
Signature
/s/ Geoffrey P. Gilmore, as Attorney-in Fact
Stock symbol
AGRX
Transactions as of
Oct 7, 2021
Transactions value $
$0
Form type
4
Date filed
10/8/2021, 05:03 PM
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGRX Common Stock Award $0 +79.6K $0.00 79.6K Oct 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Employee Stock Option (Right to Buy) Award $0 +97.1K $0.00 97.1K Oct 7, 2021 Common Stock 97.1K $0.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units that were granted on October 7, 2021, which will vest and be settled in common stock in three annual installments as follows: 26,537 shares on October 7, 2022, 26,528 shares on October 7, 2023, and 26,528 shares on October 7, 2024, subject to the Reporting Person's continued service on the Issuer's board of directors through each vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during each respective year of board service.
F2 The option was granted on October 7, 2021 and vests in three annual installments as follows: 32,379 shares on October 7, 2022, 32,369 shares on October 7, 2023, and 32,368 shares on October 7, 2024 subject to the Reporting Person's continued service on the Issuer's board of directors through each vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during each respective year of board service.